Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dovobet Foam for prurigo nodularis
jRCTs061240121Recruiting
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of calcipotriol + betamethasone in prurigo nodularis (PN). Primary endpoint: Primary endpoint: percentage change in prurigo nodules at 8 weeks. Started Feb 2025; status: recruiting.
02
Drugs
calcipotriol + betamethasone
03
Conditions
prurigo nodularis (PN)
Beyond the preview
Go deeper on jRCTs061240121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061240121.